Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
Clinical trial NCT03532451 · COMPLETED
Trial details
- NCT number
- NCT03532451
- Sponsor
- PrECOG, LLC.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-22
- Primary completion
- 2020-11-27
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.